“Going forward, PolyNovo and Beta Cell are in collaboration discussions to accelerate research anddevelopment pathways to ensure PolyNovo’s technology can play a major role in the cell therapymarket space which is estimated to be USD $34 Billion by 2034. Professors Coates andGreenwood are subject matter experts and will guide PolyNovo’s involvement.”
- Forums
- ASX - By Stock
- Ann: BTM delivers positive First in Man results in Cell Therapies
PNV
polynovo limited
Add to My Watchlist
2.27%
!
$1.29

“Going forward, PolyNovo and Beta Cell are in collaboration...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.29 |
Change
-0.030(2.27%) |
Mkt cap ! $887.7M |
Open | High | Low | Value | Volume |
$1.32 | $1.32 | $1.27 | $2.597M | 2.013M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 16792 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 46984 | 44 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 18783 | 1.290 |
17 | 34989 | 1.285 |
17 | 101280 | 1.280 |
15 | 99421 | 1.275 |
10 | 31038 | 1.270 |
Price($) | Vol. | No. |
---|---|---|
1.295 | 47346 | 41 |
1.300 | 37905 | 35 |
1.305 | 43530 | 17 |
1.310 | 39500 | 11 |
1.315 | 87062 | 6 |
Last trade - 14.41pm 31/07/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |